Exagen (XGN) said Thursday that it priced its previously announced underwritten public offering of 3.35 million common shares at $5.25 apiece for expected gross proceeds of about $17.6 million.
The company said it granted the underwriters a 30-day option to purchase up to 502,500 additional shares at the same offering price.
Exagen expects to close the offering on Friday.
Shares of Exagen were down 8.4% in recent Thursday trading.
Price: 6.26, Change: -0.57, Percent Change: -8.35